Lv4
670 积分 2025-02-05 加入
IL-18BP is a secreted immune checkpoint and barrier to IL-18 immunotherapy
10小时前
已完结
Microenvironmental regulation of solid tumour resistance to CAR T cell therapy
6天前
已完结
Benefit from huCAR19-IL18 cells in patients with CD19+ lymphomas after CAR T cells
8天前
已完结
Allogeneic CAR-T cells in lupus: Bridging the gap for a new therapeutic era?
11天前
已完结
CD4 and CD8 expression by human and mouse thymic dendritic cells
12天前
已完结
The CD8+dendritic cell subset
12天前
已完结
Selective HLA knockdown and PD-L1 expression prevent allogeneic CAR-NK cell rejection and enhance safety and anti-tumor responses in xenograft mice
13天前
已完结
In vivo CAR-T cell engineering in refractory SLE
19天前
已完结
In vivo chimeric antigen receptor (CAR)-T cell therapy
19天前
已完结
Chimeric antigen receptor T cell therapy for autoimmune disease
1个月前
已完结
皖公网安备34019202002308
